載入...
EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Stolichnaya Izdatelskaya Kompaniya
2016-01-01
|
| 叢編: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| 主題: | |
| 在線閱讀: | https://www.rpcardio.com/jour/article/view/820 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|